高剂量甲基化物和酶1在患有注意力缺陷/多动障碍的患者中的遗传变异:一系列病例
Andrie C Westerkamp1, Rob Rodrigues Pereira2, Vera R Huitema3
1From the University Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Journal of clinical psychopharmacology
|October 18, 2023
概括
三名患者的高剂量甲基酸盐 (MPH) 并不能通过CES1基因中的遗传变异来解释. 需要进一步的研究来了解MPH代谢和高剂量要求.
科学领域:
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学是一种遗传学.
- 神经科学是一个神经科学.
背景情况:
- 甲基化物 (MPH) 治疗注意力缺陷/多动障碍 (ADHD).
- 碳氧乙酶1 (CES1) 酶会代谢MPH.
- 由于药理动力学变异,一些患者需要高剂量的MPH,可能与CES1基因变异有关.
研究的目的:
- 在三名需要高剂量MPH的患者中研究CES1基因.
- 确定CES1遗传变异是否解释了改变的MPH药理动力学.
主要方法:
- 收集了三名高剂量MPH (180-640毫克) 的患者的药理动力学 (PK) 数据.
- 使用人口模型进行PK分析,将患者数据与模拟数据进行比较.
- 通过实时PCR对CES1基因进行拷贝数变异和单核酸多态 (SNP) 的基因定型.
主要成果:
- 患者的MPH血度低于预期的剂量.
- 在这些患者中,MPH的清除清除值更高.
- 没有发现与观察到较高的MPH代谢或清除相关的CES1遗传变异.
结论:
- 该研究没有发现已知的CES1遗传变异与这三名患者的MPH清除增加之间存在联系.
- 这些人需要高剂量MPH的原因尚不清楚,需要进一步调查.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
73
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
73
Human Genetics
588
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
588
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
167
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
167
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
207
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
207
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K


